Insulin Insufficiency To Affect 40 Million Diabetes Patients by 2030

Kathleen Kinder
Kathleen Kinder

Updated · Nov 27, 2018

SHARE:

News.Market.us is supported by its audience. When you purchase through links on our site, we may earn an affiliate commission. Learn more.
close
Advertiser Disclosure

At Market.us News, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us News. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Insulin is one of the most-used medicines across the world for treating Type 2 diabetes. A recently-published study, however, suggests that things would not be the same after a few years. According to this study, usage rates of Insulin are expected to rise exponentially by 2030 while the demand will also be increased. This will create a situation where many patients don’t have access to this medicine. The study was conducted by a group of researchers in Stanford University and the study has more statistics to show about how worse the conditions would turn into.

It is expected that 511 million people will be suffering from Type 2 diabetes by 2030, and the current stats are standing at 406 Million. Out of the extra people who are expected to acquire the situation, citizens of the US, China and India will be contributing the most. The research was based on the data from International Diabetes Federation, along with 14 other studies that were done on the matter. Altogether, the researchers were able to analyze the data of more than 60% of people across the world who have diabetes. The study is also showing the signs why insulin consumption would increase in the long run.

In many regions, including Africa, governments are trying to make insulin affordable for the commons in the country. This too will increase the overall consumption rates of the drug, contributing to the global trend in the long run. It is expected that more people would not be able to live without the sufficient amount of the drug. However, the real problem is the increasing price of the drug, which has been inaccessible for most of the population as well. Therefore, the team also recommends that we should analyze other methods that can reduce the dependence of insulin.

SHARE:
Kathleen Kinder

Kathleen Kinder

With over 4 years of experience in the research industry, Kathleen is generally engrossed in market consulting projects, catering primarily to domains such as ICT, Health & Pharma, and packaging. She is highly proficient in managing both B2C and B2B projects, with an emphasis on consumer preference analysis, key executive interviews, etc. When Kathleen isn’t deconstructing market performance trajectories, she can be found hanging out with her pet cat ‘Sniffles’.